GNRH1 and metabolic dysfunction-associated steatotic liver disease: The other significantly enriched pathways include Type II diabetes mellitus, Fanconi anemia pathway, Retrograde endocannabinoid signaling, GnRH signaling pathway, and Non-alcoholic fatty liver disease (NAFLD) which seems to be the risk factors of myocardial infarction.